PCSK9: The promise of a new target in lipid management
Prof. John E Deanfield, UCL, London
Educational information
The educational programme at ESC was CME accredited by EBAC.
This online session is not accredited, but similar in content
Prof. John E Deanfield, London introducing the rationale for PCSK9 inhibition with a lecture held during the EBAC accredited symposium on innovations in lipid management at ESC 2014 in Barcelona
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: